Related to Narrow Plurality Sees High Court Siding with Mayo Over Prometheus in Dx Patent Case

• Leroy Hood-Led Venture Kicks Off with $30M
  
• Pikamab Secures Patents that Will Enable Development of Theranostic for Lupus
  
• Biocartis to Pocket Roughly $14.9M in Series A Financing
  
• FDA Clears Abbott’s Rheumatoid Arthritis Test
  
• Genetic Tech to Distribute Rosetta’s Cancer Tests in Australia, New Zealand, and Singapore
  
• ZyGEM and Phthisis Diagnostics to Develop Tools to Detect Infectious Pathogens
  
• BD to Acquire HandyLab for Molecular Diagnostic Automation Platform
  
• Bio-Rad to Pay Biotest Roughly $67.5M for Certain Diagnostics Businesses
  
• Thermo Fisher Scientific Launches Biomarker Test for Heart Attack in Europe
  
• FDA Approves AdvanDx’ Faster PNA FISH Protocol for Identifying Enterococcal Bloodstream Pathogens
  
• Biosearch Grants Micronics Rights to Its Nucleic Acid Assay Chemistries
  
• FDA Grants Emergency Use Authorization to Gen-Probe's PCR Test for the H1N1 Flu
  
• Calbiotech Wins Phase I SBIR Contract to Develop Blood-Based Dengue Fever Diagnostic
  
• Chinese Authorities Clear China Medical’s Leukemia Diagnostic Kit
  
• Inostics Gains License from JHU for Development of Cancer-Related Mutation Testing
  
• Enzo to Market GeneNews’ Colorectal Cancer Blood Test in NY and NJ
  
• Exact Sciences Fortifies Position in Stool-Based DNA Detection Through Deal with Hologic
  
• Proven Diagnostics to Provide Cardiovascular Tests from Berkeley HeartLab
  
• Biofortuna Chooses Lab901’s ScreenTape System for Multiplex PCR Diagnostic Kits
  
• EraGen and Illumina Enter Cross-Licensing Deal for Molecular Diagnostics